Latest news
30-03-2022 - Annual Deadlines Announced for Two Alzheimer's Drug Discovery Foundation (ADDF) Funds
Funding is available through the ADDF/AFTD Accelerating Drug Discovery for Frontotemporal Degeneration (open worldwide) and the ADDF-Harrington Scholar Program (open to applicants in the US, Canada and UK).
Founded in 1998 and based in the US, the Alzheimer's Drug Discovery Foundation (ADDF) seeks to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease. Application deadlines have been announced for the ADDF/AFTD Accelerating Drug Discovery for Frontotemporal Degeneration (open worldwide) and the ADDF-Harrington Scholar Program (open to applicants in the United States, Canada and the United Kingdom).
[...]